Showing results (721-730 of 3,032) with videos related to
Sort By:
Pageof 304
International Journal of Clinical Pharmacology and Therapeutics|November 16, 2023
Monitoring of blood levels in patients administered CYP3A4 inhibitor during the maintenance phase of venetoclax administrationToshiki Kubo, Shunsuke Matsuo, Rintaro Sogawa, et al.International Journal of Clinical Pharmacology and Therapeutics|November 9, 2023
Analysis of risk factors for hypoglycemia in patients with gastrointestinal bleeding induced by somatostatin for injection and establishment of the prediction modelHong Zhang, Lei Chen, Xiaoying Wang, et al.International Journal of Clinical Pharmacology and Therapeutics|August 7, 2023
Voriconazole-induced visual abnormality based on drug interaction between voriconazole and esomeprazole: A case reportZhouqian Jiang, Jia Li, Chengfei Zhao, et al.International Journal of Clinical Pharmacology and Therapeutics|June 29, 2023
Evaluation of the comparative pharmacokinetic properties of a new orally disintegrating tablet of tegoprazan in healthy Korean subjectsJin A Lee, In Sun Goak, Jiwon Lee, et al.International Journal of Clinical Pharmacology and Therapeutics|June 22, 2023
Factors influencing glomerular filtration rate as estimated using preoperative creatinine and cystatin C levelsFumihiro Nishimura, Kentaro Oniki, Shigeyuki Miyamura, et al.International Journal of Clinical Pharmacology and Therapeutics|June 22, 2023
Factors affecting outcome in hospitalized patients treated according to recommendations from clinical pharmacologistsMarko M Folic, Slobodan M JankovicInternational Journal of Clinical Pharmacology and Therapeutics|March 17, 2026
Can tiotropium add-on inhalation revolutionize therapy in elderly asthmatic patients? A treatable traits approach towards successful agingYoshihisa Ishiura, Shosaku Nomura, Noriyuki Ohkura, et al.International Journal of Clinical Pharmacology and Therapeutics|February 22, 2026
Low-dose lamotrigine co-administration decreases quetiapine plasma concentrations: Effect of UGT2B7-161C>T polymorphism in Japanese patients with depressionTakeshi Suzuki, Goyo Nagai, Kazuo Mihara, et al.International Journal of Clinical Pharmacology and Therapeutics|May 11, 2026
Evolocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, is effective and safe in the treatment of hyperlipidemia in chronic kidney disease stage 3 - 4Hongxu Zhu, Yufeng Chang, Qi JinInternational Journal of Clinical Pharmacology and Therapeutics|April 23, 2026
Inflammatory cytokines, autoantibodies and salivary gland function in Sjögren's syndrome: Effects of T. wilfordii as Hook F medical wine and Tripterygium glycosides tabletsXiaofu Yu, Pan Chu, Chengcheng Yu, et al.Pageof 304